Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

CarraShield Labs Issued Ground-breaking Patent for Anti-viral Gel Technology Used to Prevent HPV Infections


News Image

While the HPV vaccine protects against at the most nine strains of the virus, potentially, the carrageenan-based lubricant can provide total protection from HPV.

CarraShield Labs, Inc. is pleased to announce the issuance of US Patent 10,688,043, the first in a series of patent filings developed by its Chief Scientist, Dr. Mario Tremblay, covering the unique, natural, anti-viral gel technology marketed as CarraShield® and available over-the-counter in a personal lubricant called Divine 9®. The technology uses a highly unique sea algae extract as the active ingredient, resulting in a product that is not only the first of its kind to show efficacy against human papillomavirus (HPV), but also one that is naturally derived. Divine 9 with CarraShield is the first and only personal lubricant formulated with a sea algae extract, commonly referred to as carrageenan, to be FDA-approved as a Class II Medical Device.

Published independent clinical results from the CATCH (Carrageenan-gel Against Transmission of Cervical HPV) McGill University Medical School Phase IIb study shows that women can reduce the risk of contracting cancer and wart-causing HPV infections by using Divine 9 personal lubricant from CarraShield Labs with its patent-protected CarraShield technology. In the CATCH study, the McGill team evaluated the long-term use of Divine 9 by hundreds of women. They found that using Divine 9 personal lubricant in each intimate encounter reduced the number of new HPV infections as compared to using a standard lubricant.

CarraShield Labs’ patented gel technology was first tested in groundbreaking work at the National Cancer Institute. The National Cancer Institute’s in vitro and in vivo studies showed CarraShield Labs’ Divine 9 personal lubricant to be highly effective in blocking infection by the human papillomavirus (HPV). This was followed by confirmatory studies at the Albert Einstein College of Medicine and joint work with The Population Council. The in vitro studies also demonstrated the superiority of the patented CarraShield carrageenan versus other carrageenan types, even at low concentrations.

There are approximately 470,000 cases per year of Invasive Cervical Cancer (ICC) globally; comprising 10% of all female cancers and it is the second most prevalent cancer in women after breast cancer. HPV is also strongly linked to penile, vaginal/vulvar and anal cancers as well as being the root cause of genital warts. The detection of oral HPV infection has also increased significantly in the past 10 years, which is linked to a rising number of cases of oral, neck and throat cancers.

The CarraShield gel technology opens up entirely new ways to help prevent HPV-induced cancers and warts above and beyond vaccines. Current HPV vaccines only protect against up to 9 types of HPV virus out of over 200 HPV types. It is estimated that only 107 million women have been vaccinated out of a global population of 2.8 billion. “While the HPV vaccine protects against at the most nine strains of the virus, potentially, the carrageenan-based lubricant can provide total protection from HPV,” stated Dr. Eduardo Franco, Principle Investigator, University of McGill Medical School.

The newly patented CarraShield technology works as a protective barrier, with no chemical interactions with the body. The barrier mechanism works to reduce transmission from infected individuals by blocking and containing viral shedding. This barrier technology is now being tested with COVID-19 as a means of reducing the spread and severity of the global pandemic. The Company will also soon begin clinical testing products to prevent oral HPV transmission.

About CarraShield Labs, Inc.

CarraShield Labs, Inc., combines nature with science to create products that improve well-being and overall health. Intensive research has led to the company’s proprietary, naturally derived sea algae concentrate called CarraShield®. The first product to contain CarraShield is Divine 9®, a water-based personal lubricant used to help prevent HPV infections in women. For information on distribution and licensing opportunities, contact the company at http://www.carrashieldlabs.com.

Share article on social media or email:

Sway Medical Closes Series A Financing Round


“Sway Medical’s novel approach to mobile neurological assessment makes it easy to evaluate patients remotely with the devices they already own.” Dr. William Paiva

Sway Medical, a mobile neurological assessment company, recently closed a $4.2M Series A financing round led by Atento Capital and the Oklahoma Life Science Fund (OLSF). The funding brings Sway Medical back to Tulsa, OK, where it was founded in 2011. Additional participation in the financing round included ADG Venture Group, Cortado Ventures, Progeny Plus Capital Partners, Innovation in Motion (iiM), William S. Smith, and Eric Warren.

Sway Medical has become a leader in mobile balance testing and cognitive assessment with substantial growth over the past two years. CEO and Founder Chase Curtiss returned to the company in 2018 to lead a resurgence of the Sway product platform, adding new novel cognitive tests, cross-platform validation, and substantial growth in utilization. In August, Sway reached a weekly record of nearly 100,000 tests. “Sway’s customer base has grown exponentially in 2020, even with the challenges of COVID-19 for fall sports,” said Curtiss.

According to CB Insights The State of Healthcare Report Q2’20, digital health investment was up 22% to $5.8B, the second best-performing quarter for funding on record. Dr. William Paiva of OLSF acknowledged, “There are tremendous growth opportunities in digital health as medicine moves to more remote patient management. Sway Medical’s novel approach to mobile neurological assessment makes it easy to evaluate patients remotely with the devices they already own.” This growth trend is happening throughout healthcare in companies that remotely connect patients to healthcare professionals. “It’s validating to see the market trend, significant customer growth, and backing from highly successful healthcare investors like Dr. Paiva of OLSF,” Curtiss stated.

The financing will enable the Sway team to expand in Tulsa by adding to a world-class product team and sales organization. “We see Sway as a true Tulsa story of where innovation and scrappiness collide with resilience and Grit. With Chase at the helm, we are excited about Sway’s return to Tulsa and expansion into several new lines of business. We believe this next Chapter in Sway’s story will be the first of many and are excited to see Sway drive towards its potential in the months and years to come.” said Michael Basch, Managing Partner of Atento Capital. CEO and Founder Chase Curtiss added, “The Sway team is excited for the opportunity to bring a high-growth and design-focused company back to Tulsa. We believe the future of medicine is mobile and device agnostic, which is one of the key advantages to the Sway platform. We have proven a high level of accuracy across Apple and Android devices.”

Sway has expanded clinical utilization with investment in research and further validation, including over 60 published research papers driven from strong relationships with academic research institutions. “Research collaborations with Harvard, Wichita State, University of Oklahoma, Duke Medicine, and many others are driving quality research and validation to improve product utility for our clinical customers,” Labiba Russo, Senior Vice President added.

Sway is the most clinically-validated mobile assessment tool for balance and cognitive function with rigorous quality testing. Sway is an MDSAP certified medical device manufacturer with clearance in the United States, Canada, the European Union, and Australia. “Product innovation is a part of our DNA,” Curtiss added, “We are constantly listening to our customers and improving the Sway experience to bring the design-first mentality to medical software.”

Sway addresses a clear need for more objective measures of neurological function. From evaluating fall risk or cognitive decline in seniors to objectivity in evaluating athletes, Sway is pioneering cross-platform mobile assessments.

“Sway is such an easy tool to administer. It allows our users to collect objective data very quickly in the clinic or remotely from the patient’s device,” said Jordan Beacham, VP of Software at Sway. “Our customers love what we are building, and we are excited about the future direction of Sway.”

For more information on Sway Medical, visit https://swaymedical.com

About Sway Medical:

Sway medical provides mobile software for neurological assessment with patented tests that leverage the accuracy of sensors built into any mobile device. Sway’s FDA cleared testing platform allows users to test balance and cognitive performance in the clinic or remote on any mobile device. With over 60 research publications and over one million tests, Sway is the leader in mobile neurological assessment.

Share article on social media or email:

EZ Texting Selected for COVID-19 National Daily Health Survey


News Image

EZ Texting has been selected by Stanford Medicine to support its National Daily Health Survey (NDHS) to learn and predict which geographic areas in the United States will be most impacted by COVID-19. Text reminders are being delivered by EZ Texting to prompt thousands of participants to complete the NDHS survey.

The survey tracks the occurrence of possible COVID-19 symptoms in communities, collecting data that could flag an uptick in COVID-19 cases before they reach a hospital. Acting as an early warning system for regions of the United States with large populations of undiagnosed individuals, the information will be used to inform local and national responses to the pandemic, such as directing medical resources and improving policies and public guidance for mitigating the impact of the disease.

Potential early warning signs from the survey are critical, enabling decision-makers to respond proactively before infections get out of hand and providing public health officials with a geographic area assessment of infections within the population.

“EZ Texting is proud to support this worthwhile initiative to help local communities during the crisis and inform resource allocation across hospital systems,” said Norman Happ, CEO of EZ Texting. “In the one month since launching our service, 20,000 participants are responding to text reminders and completing the survey.”

SMS notifications provide a fast, easy and direct alternative to email. EZ Texting’s core mission is to enable its customers and partners to engage with their audiences quickly and efficiently through the power of text communications. Other organizations have built smartphone apps, but not everyone finds them simple to download and install, with underlying concerns about being too intrusive. Additionally, the ease of use of text messaging can potentially enable greater participation in the survey by underrepresented parts of society.

About EZ Texting

Founded in 2004, EZ Texting has served over 160,000 customers and is the #1 SMS marketing software, setting the standard for business texting platforms. Our messaging solutions are featured as a top 20 Best Product for Marketers and allow businesses of all sizes to reach and engage their mobile audiences. With employees from Austin to Kiev, EZ Texting is a SaaS company that delivers the fastest, easiest, and most reliable way to connect. Backed by Morgan Stanley Expansion Capital, Investor AB, and ROCA Partners, EZ Texting is continuously voted a Best Place to Work.

Text “TRY” to 858585 to see how it works.

Contact:

Ali Nagy

PR for EZ Texting

alessandra@bospar.com

Share article on social media or email:

Jump Technologies introduces data visualization capabilities to help hospitals prepare for and prevent supply chain collapse due to COVID-19 resurgence


Category report image.

Jump Technologies’ expanded capabilities make it easy for hospitals to monitor the location of all supplies and track who is using what.

The answer is not simply buying more masks, it’s about using the power of advanced analytics to create a collaborative healthcare supply chain ecosystem.

Jump Technologies, a leading hospital supply chain solutions provider, announced today the expansion of its JumpStock capabilities to include data analytics and supply chain visualizations that give hospitals and health systems the ability to monitor the location of all supplies — including critical items like personal protective equipment (PPE) — across one or multiple locations, and to see who’s using what, how much they’re using, and forecast when they will stock out. This level of real-time data is essential to proactively managing supplies to avoid another healthcare supply chain collapse, should the United States be hit by a COVID-19 resurgence.

“The healthcare supply chain failed when COVID-19 hit earlier this year, putting patients and hospital workers at risk, forcing the economy to shut down, and costing taxpayers trillions. Meanwhile, cancelled services impacted patient health and caused hospitals to lose millions in revenue,” said John Freund, CEO of Jump Technologies. “To get in front of a potential COVID resurgence, hospitals need visibility and visualization up and down the healthcare supply chain. The answer is not simply buying more masks, it’s about using the power of advanced analytics to create a collaborative healthcare supply chain ecosystem.”

According to Freund, the expanded data analytics capabilities in JumpStock are critical to hospitals because they allow supply chain staff and nurses to:


  • Keep clinicians, patients, and the broader community safe and avoid unnecessary illness and loss of lives.
  • Avoid stocking out of items like PPE.
  • Reduce the potential for theft and hoarding of supplies.
  • Accurately adjust orders to meet impending demand.
  • Seamlessly manage supplies from multiple vendors, including non-traditional sources like community donations.
  • Quickly create real-time reports to fulfill internal and public reporting requirements.

JumpStock is a cloud-based hospital supply chain software solution that integrates with any enterprise resource planning (ERP) system and/or electronic medical record (EMR) system, empowering hospitals to proactively manage all supplies at one location, or across an entire health system.

“Jump Technologies is on a mission to reimagine healthcare supply chain to save lives, and that starts with giving hospitals the power to accurately forecast supply utilization and make real-time decisions based on data analytics, rather than institutional knowledge or guesswork. We’re thrilled to bring these new capabilities to hospitals everywhere at such a critical time for our healthcare system,” said Freund.

To learn more about Jump Technologies, visit http://www.jumptech.com.

About Jump Technologies

Headquartered in Eagan, MN, Jump Technologies creates safe, simple, and cost-effective solutions that help hospitals reduce stockouts, overordering, and waste, while increasing inventory turns and improving billing accuracy across a facility or system. The company’s JumpStock solution facilitates data-driven decision making that allows hospitals to save time, free up cash, and improve nurse satisfaction with supply chain. To learn more, visit http://www.jumptech.com or call (888) 373-7226. Follow Jump Technologies on LinkedIn and Twitter @JumpTechNews.

Media contact: Barbara Tabor, APR / (651) 230-9192 / barbara@taborpr.com

Share article on social media or email:



Data Shows Most Significant Increase In Uninsured In Almost A Decade – Right Before Pandemic Hit


“History has shown us that those who bear the brunt of poverty inequities—people of color, non-citizens, women-headed households—are also hit the hardest when recessions come. Similarly, those with least access to healthcare, even in the good times, are at highest risk during health emergencies.”

Data released today from the U.S. Census Bureau revealed that health insurance coverage rates declined in Illinois and throughout the nation in 2019, continuing a disturbing trend of eroding the gains of the Affordable Care Act (ACA), right before a global pandemic and economic recession hit.

Nationwide, the number of uninsured people climbed by one million people from 28.6 million (8.9%) in 2018 to 29.6 million people (9.2%) in 2019. Illinois’s overall uninsured rate (7.4%) grew for the second time in the past three years, and uninsured rates for non-seniors went up from 8.1% in 2018 to 8.6% in 2019—the third year in a row. Illinois saw a decline in Medicaid coverage for over 121,000 non-seniors from 2018 to 2019, a drop of 0.8 percentage points. The majority of the people who lost Medicaid were in the Chicago six county area.

Conditions are likely to have worsened amid the coronavirus pandemic. In 2020, it is estimated 846,000 Illinoisans lost employer-sponsored insurance due to job loss during the pandemic,[1] and Illinois has experienced more modest increases in Medicaid enrollment during the pandemic than the rest of the nation.[2]

“History has shown us that those who bear the brunt of poverty inequities—people of color, non-citizens, women-headed households—are also hit the hardest when recessions come. Similarly, those with least access to healthcare, even in the good times, are at highest risk during health emergencies,” said Katie Buitrago, director of research at Heartland Alliance. “We currently face both a pandemic and a recession. This data shows us that millions were already living on the edge heading into 2020; the federal government must act immediately to ensure that they don’t fall off entirely.”

In 2019, Trump administration officials continued to neglect and sow confusion within the ACA health insurance marketplace, and pursue extreme and punitive immigration policies that discouraged enrollment in health insurance. Court battles likely confused people about the status of the ACA and depressed enrollment. And ongoing battles related to the public charge immigration rule only worsened the situation.

“The continued erosion of health insurance coverage in 2019 was not surprising,” said Dan Rabbitt, senior health policy manager for Heartland Alliance. “The Trump administration has undermined the ACA at every turn and has discouraged immigrant communities from accessing the public benefits they are entitled to. This resulted in some families not being covered by health insurance right before the COVID pandemic hit—and many more families losing insurance due to unemployment in 2020. Every person deserves to have access to health care, especially during the worst public health crisis of our lifetimes.”

In addition to this nationwide decline in the number of uninsured, the new data found that the official poverty rate in the United States declined to 10.5 percent, a 1.3 percentage point drop from 2018, and Illinois’s rate dropped to 11.5 percent. This year marks the lowest poverty rates observed nationwide since estimates were published in 1959. This is also the first year that poverty rates in Illinois were below pre-2008 recession levels, meaning that the state’s poverty rates took 11 years to recover from the previous recession. However, we can’t lose sight of the fact that a staggering 34 million Americans and 1.4 million Illinoisans were living in poverty and still struggling every day to meet their most basic needs, even before the pandemic. In addition, the national data on poverty was collected amidst the pandemic, resulting in much lower response rates that could understate the true extent of poverty.

It is important to note that these data reflect conditions in 2019—the last year of an economic expansion, before the pandemic-related recession hit. A historic global pandemic and the ensuing economic crisis in 2020 will tell a much different story than the one we see from 2019. Indeed, initial data from smaller but more recent Census surveys already paint a more troubling picture.[3] Nationwide, 45.3% of adults report living in a household where someone has lost income from work since mid-March 2020 (that figure is 43.1% for Illinois). And 56.2% of Latinos in the U.S. (54.8% in Illinois), and 52.2% of Black people (54.4% in Illinois), have lost household income since mid-March 2020. As we look forward to and plan for eventual recovery, 2019 data will be the new benchmark for getting back to where we were.

Heartland Alliance Poverty Experts Available for Commentary

Additional findings from the release revealed:


  • Over 630,000 Illinoisans are living in extreme poverty—meaning a family of three is living on less than about $10,168 per year. It is estimated that a family of three in Illinois needs about $65,000 a year to make ends meet.
  • There are 4 million people experiencing poverty in Illinois. Poverty rates are 1.8 to 3.1 times higher for Illinoisans of color.
  • Illinois median household income increased from 2018 to 2019, and in 2019 was $69,187. This is the first year that median household income exceeded 2007, before the previous recession (2% or $1,380 higher than 2007).
  • Black households were the only major racial/ethnic group in Illinois who did NOT experience an increase in household income from 2018 to 2019. Household income increased for Asian households (9.4%), White households (3.5%), and Latino households (6.1%) from 2018 to 2019.
  • Poverty rates for children, female-headed households, and communities of color remain dramatically higher than the overall rate. 39 percent of Illinoisans in poverty work, and 31 percent of Illinoisans in poverty are children. Over half (51 percent) of Illinoisans in poverty are Black or Latino.
  • 23% of Illinois renter households pay more than half of their income in rent.

Read the fact sheet on Illinois and Chicago region poverty, income, and health insurance trends based on the newly released data. https://socialimpactresearchcenter.issuelab.org/resource/poverty-income-health-insurance-update-illinois-and-chicago-region.html

Access interactive local data for Chicago Community Areas, all cities and townships in the six-county Chicago metropolitan region, and all counties in Illinois. https://www.heartlandalliance.org/data-dashboards/

Access the Census Bureau’s local demographic, social, economic, and housing data that were released today for places with populations of 65,000 or more. Contact Heartland Alliance for assistance accessing and interpreting the data. http://data.census.gov/

###

Heartland Alliance, one of the world’s leading anti-poverty and human rights organizations, works in communities in the U.S. and abroad to serve people experiencing homelessness, living in poverty, or seeking safety. The organization provides a comprehensive array of services and advocates for policy change in the areas of safe and justice, health and healing, and economic opportunity. For more information visit, http://www.heartlandalliance.org

Heartland Alliance Research & Policy – Heartland Alliance’s Research & Policy Division focuses on the realization of human rights through ending poverty, racism, and injustice by engaging in research on social issues and solutions, policy and systems change, and field building nationwide. Learn more on the Research & Policy webpage: https://www.heartlandalliance.org/program/research-and-policy/.

1 https://www.kff.org/report-section/eligibility-for-aca-health-coverage-following-job-loss-appendix/

2 https://www.cbpp.org/blog/medicaid-enrollment-continues-to-rise

3 Table 1: https://www.census.gov/data/tables/2020/demo/hhp/hhp13.html

Share article on social media or email:

CHC Wellbeing Underwrites WELCOA Inner Circle on Preventing Burnout and Building Resilience


News Image

Now, more than ever, we have to ensure we are building empathetic and supportive cultures that prioritize the mental health of employees.

A select group of employers across the country began a learning journey today to improve the emotional wellbeing of their populations by participating in WELCOA’s Inner Circle on Preventing Burnout and Building Resilience. As the official underwriting sponsor of the Inner Circle, CHC Wellbeing will be collaborating alongside 100 other organizations to address the challenge of employee burnout and to develop tools for increasing resilience in the workplace.

The WELCOA Inner Circle is a workshop series for attendees to learn about the science of burnout and how to bolster employee wellbeing. The course will be highly interactive, as participants will work together to create solutions that can be applied immediately by their respective organizations. Led by positive psychology expert Stella Grizont, the Inner Circle will focus on what employees need to support their energy, motivation and engagement at work.

“We are proud to support this important initiative by WELCOA because it squarely addresses one of the biggest challenges facing our workforces,” said Ramki Ramanarayanan, CEO of CHC Wellbeing. “Employers need practical, effective solutions that help them care well for the emotional wellbeing of their teams. Now, more than ever, we have to ensure we are building empathetic and supportive cultures that prioritize the mental health of employees.”

A recent 2020 Wellness Trends survey by CHC and WELCOA identified that emotional wellbeing is a top wellness-related concern for the majority of employers. Stress, anxiety, depression and other related challenges were already growing needs across the United States as we entered this year. Recent events have magnified the trend.

According to a recent global study, 47 percent of employees are feeling burned out since the beginning of the COVID-19 crisis. This is a critical statistic, because burned out employees are more likely to quit, take a sick day and visit an emergency room.

“No approach to wellbeing is complete without a conversation about burnout and resilience,” said Sara Martin, CEO of WELCOA. “Employees are carrying a heavy load right now, and they need help to lighten it. They need more time, more tools and more resources so they are better equipped to bounce back.”

The WELCOA Inner Circle on Burnout and Resilience runs for the next six weeks. Once completed, members of WELCOA will be able to access key learnings from the group via their member resources page.

About WELCOA

WELCOA (The Wellness Council of America) is the nation’s most respected resource for building high-performing, healthy workplaces. Throughout its 30+ year history as a nonprofit, WELCOA has perfected its patented Well Workplace protocol which is the key to developing, delivering, and sustaining a healthy corporate culture. Today, over 30,000 workplace wellness practitioners, human resources professionals, business leaders and consultants rely on WELCOA for tools, trainings and its Premier Provider Network (PPN) partners to move their wellness programs forward.

About CHC Wellbeing

CHC Wellbeing goes beyond wellness to true potential, helping individuals excel in every facet of their lives: physically, emotionally, socially and financially. With a proven track record of serving over a thousand clients, our evidence-based wellbeing strategies reduce costs, improve productivity and nurture an environment where people do their best work. Learn how you can reach your true potential by visiting http://www.chcw.com.

Share article on social media or email:

2020 Blavatnik Regional Awards for Young Scientists Honorees Announced during National Postdoc Appreciation Week


“Scientists strive to solve the world’s most urgent problems, leading to further discovery, innovation, economic growth, and societal progress.” – Len Blavatnik

Today, during National Postdoc Appreciation Week, the Blavatnik Family Foundation and the New York Academy of Sciences announced the three Winners and six Finalists of the 2020 Blavatnik Regional Awards for Young Scientists. The Blavatnik Regional Awards honor outstanding postdoctoral scientists from academic research institutions across New York, New Jersey, and Connecticut and recognize researchers in three scientific categories: Life Sciences, Physical Sciences & Engineering, and Chemistry. A distinguished jury of leading scientists and engineers from across the New York region selects, in each category, one Winner, who is awarded a $30,000 unrestricted prize, and two Finalists, who are each awarded $10,000. For the 2020 competition, there were 154 outstanding nominations from 24 academic institutions in the New York metropolitan region (Tri-State area). The 2020 Blavatnik Regional Awards Winners and Finalists will be honored alongside the 2020 and 2021 Blavatnik National Awards honorees on September 27, 2021, at the American Museum of Natural History in New York.

The 2020 Blavatnik Regional Awards Winners are:


  • Life Sciences: Antonio Fernández-Ruiz, PhD, nominated by New York University


Antonio Fernández-Ruiz has expanded our understanding of how neurons in the brain coordinate their activity to support our ability to form and recall memories. By uncovering the mechanisms of this coordinated activity in the brain, he was also able to alter how neurons are reactivated, demonstrating that memory can be improved artificially. Fernández-Ruiz will be transitioning to a tenure-track position at Cornell University in July, 2021.

  • Physical Sciences & Engineering: Adrian Price-Whelan, PhD, nominated by Flatiron Institute Adrian Price-Whelan’s innovative use of advanced statistical analysis and computational techniques has unlocked one of the biggest mysteries of the universe—dark matter. Utilizing satellite data to analyze the motions of stars throughout the outer regions of the Milky Way, Price-Whelan’s work has provided the first clear evidence of dark matter substructure in the outskirts of our galaxy.
  • Chemistry: Ning Jia, PhD, nominated by Memorial Sloan Kettering Cancer Center


Ning Jia has unlocked key biological mechanisms that govern the function of enzymes and CRISPR-Cas systems, such as those used in gene editing. Jia’s research has provided scientists with an enhanced understanding of the functions and structure of individual atoms in biological molecules. In the case of her work on CRISPR-Cas systems, this detailed knowledge is necessary if we are to demonstrate that gene-editing can be used in the future to cure certain genetic diseases.

“Scientists strive to solve the world’s most urgent problems, leading to further discovery, innovation, economic growth, and societal progress,” said Len Blavatnik, Founder and Chairman of Access Industries, head of the Blavatnik Family Foundation, and member of the President’s Council of the New York Academy of Sciences. “Our nation’s thriving scientific ecosystem is reliant, to a large degree, on scientists and engineers coming to America to study and conduct research. I’m pleased that our 2020 honorees hail from multiple countries, highlighting yet again how essential it is for scientists the world over to work together to address humankind’s greatest challenges and improve the quality of life for everyone.”

Nicholas B. Dirks, the New York Academy of Sciences’ new President and CEO said: “Postdocs are the fuel running the engines of scientific research. We are incredibly proud to announce these outstanding postdoctoral Winners and Finalists of the 2020 Blavatnik Regional Awards, especially during National Postdoc Appreciation Week—a week dedicated to recognizing the significant contributions that postdoctoral scholars make to American research and discovery. The Academy, through administering programs for postdoctoral scientists such as the Blavatnik Regional Awards and Science Alliance, is committed to supporting these young investigators as they transition to the next stages in their career and beyond.”

The following postdoctoral researchers have been named Finalists in their respective categories:

Life Sciences

  • Amelia Escolano, PhD, nominated by The Rockefeller University


Amelia Escolano was recognized for her groundbreaking HIV research, designing a novel immunization procedure that could lead to a vaccine against HIV-1. By sequentially exposing mice to several different forms of a protein found on the HIV-1 virus over a five month period, Escolano was able to train the immune system to make antibodies that neutralize a broad diversity of strains of the rapidly mutating HIV-1 virus.

  • Marc Schneeberger Pané, PhD, nominated by The Rockefeller University


Marc Schneeberger Pané has discovered that a specific area of the brain usually associated with mood and wakefulness also controls energy balance and body weight by regulating feeding behavior and body temperature. Two types of neurons in this area are activated by different energy states (hunger, satiety) or with temperature challenges (heat). Importantly, activation of these neurons leads to strong effects in feeding or temperature regulation. As a result body weight is changed. Obesity is a disease in which energy balance is dysregulated, so this new finding offers promise for developing novel drugs to treat this chronic, widespread condition.

Physical Sciences & Engineering

  • Zahra Abdollahnejad, PhD, nominated by University of Connecticut


Zahra Abdollahnejad was recognized for the design and development of green construction materials for buildings. Concrete is responsible for 4-8% of the world’s global carbon dioxide (CO2) emissions. Through her development of specialized mixtures of environmentally-friendly concretes, mortars, and insulating foams, Abdollahnejad could significantly reduce the impact of concrete on global warming by a 50-90% carbon footprint compared to cementitious compositions, making newly constructed buildings more energy-efficient. She is also trying to develop sustainable construction materials with near-zero CO2 emissions. Her work is re-shaping how the construction industry uses concrete, creating more sustainable buildings for our future.

  • Shruti Puri, PhD, nominated by Yale University


Shruti Puri was recognized for her extraordinary theoretical discoveries in quantum information storage and quantum computing. In quantum computing systems, error (noise) is an obstacle to accuracy and computational advantage. Puri’s rigorous theoretical and mathematical treatment of error led to the discovery of a completely new way of storing information in microwave photons (quanta of light), known as the Kerr-cat quantum bit. Puri’s discovery makes the path towards scalable quantum computing technologies truly possible, by tailoring the errors affecting the quantum bit in such a way that they become relatively easy to correct. Puri has recently been promoted to a tenure-track position at Yale University.

Chemistry    

  • Xianwen Mao, PhD, nominated by Cornell University


Xianwen Mao has developed a first-of-its-kind technique called COMPEITS (competition-enabled imaging technique with super-resolution) that allows for real-time optical imaging of non-fluorescent processes—processes that do not give off energy in the form of visible light. His groundbreaking technique allows for the visualization of various classes of non-fluorescent systems and processes, such as surface reactions, neurotransmitters, and chemical warfare agents—all with high resolution and under realistic conditions. This technique could be extremely useful in fields including neuroscience, materials engineering and nanotechnology, where many critical processes are non-fluorescent.

  • Yifei Zhang, PhD, nominated by Columbia University


Yifei Zhang has uncovered the principles that govern the overall activity of enzyme cascade reactions—a sequence of successive chemical reactions naturally occurring in living cells. By understanding the interplay between reaction and transport, he has shown that it is possible to engineer cellular components to perform programmable and predictable functions in vitro, including the synthesis of small molecule drugs and therapeutics.

About the Blavatnik Awards for Young Scientists

The Blavatnik Awards for Young Scientists, established by the Blavatnik Family Foundation in the United States in 2007 and independently administered by the New York Academy of Sciences, began by identifying outstanding regional scientific talent in New York, New Jersey, and Connecticut. The Blavatnik National Awards were first awarded in 2014, and in 2017, the Awards were expanded to honor faculty-rank scientists in the United Kingdom and in Israel. By the close of 2020, the Blavatnik Awards will have conferred prizes totaling over $10.2 million to 321 outstanding young scientists and engineers from more than 46 countries, representing 36 scientific and engineering disciplines. For updates about the Blavatnik Awards for Young Scientists, please visit http://www.blavatnikawards.org or follow us on Facebook and Twitter (@BlavatnikAwards).

About the Blavatnik Family Foundation

The Blavatnik Family Foundation is an active supporter of world-renowned educational, scientific, cultural, and charitable institutions in the United States, the United Kingdom, Israel, Russia, and throughout the world. The Foundation is headed by Len Blavatnik, a global industrialist and philanthropist and the Founder and Chairman of Access Industries, a privately-held industrial group based in the US with global strategic interests. Visit: http://www.accessindustries.com or http://www.blavatnikfoundation.org.

About the New York Academy of Sciences

The New York of Academy of Sciences is an independent, not-for-profit organization that since 1817 has been committed to advancing science for the benefit of society. With more than 20,000 Members in 100 countries, the Academy advances scientific and technical knowledge, addresses global challenges with science-based solutions, and sponsors a wide variety of educational initiatives at all levels for STEM and STEM related fields. The Academy hosts programs and publishes content in the life and physical sciences, the social sciences, nutrition, artificial intelligence, computer science, and sustainability. The Academy also provides professional and educational resources for researchers across all phases of their careers. Please visit us online at http://www.nyas.org.

Media contact:

Kamala Murthy

Kmurthy@nyas.org

212-298-3740

AltMed Enterprises Expands North, Securing Licensing Agreement in Canada with Atlas Growers for Distribution Nationally via Shoppers Drug Mart


News Image

We are thrilled to be able to bring our MÜV line to Canada. Canadian consumers are sophisticated and well versed on what’s available, and we know our products will stand out among the best.

Alternative Medical Enterprises, LLC is teaming up with Canada’s premier medicinal cannabis producer, Atlas Growers Ltd. to bring AltMed’s MÜV™ product formats to Canadians under the Atlas Thrive banner. Atlas Growers has finalized a distribution deal with the largest pharmacy chain in Canada, Shoppers Drug Mart, which has more than 1,300 stores nationwide.

Atlas Thrive – Powered by MÜV™ will roll out across Canada in Q4 with a variety of product formats including transdermal patches, transdermal gels, tinctures and capsules all using the patented EnCaps™ technology which delivers more effective, faster-acting and longer-lasting effects for patients.

According to ‘Statistics Canada’, as of July 2019, Canada’s cannabis sector contributed $8.26 billion to the country’s gross domestic product. Two years ago, Canada became only the second country in the world to legalize adult use of cannabis.

“We are thrilled to be able to bring our MÜV line to Canada,” said Mike Smullen, Chairman and CEO of AltMed Enterprises. “Canada is a mature market with medical cannabis first legalized in 2001 and adult use recreational in 2018. Canadian consumers are sophisticated and well versed on what’s available, and we know our products will stand out among the best.”

Sheldon Croome, Atlas President & CEO, noted, “We are proud to be partnering with a company like AltMed, a leading medical cannabis company in the US, whose values align with those of Atlas. As a medicinal cannabis producer, we are focused on providing patients with consistent, predictable and effective products and by introducing new smoke-free delivery methods our aim is to offer products that take all aspects of health into consideration to improve the lives of Canadian medical patients.”

AltMed’s MÜV EnCaps products are for patients who prioritize a smoke-free delivery method that is both long-lasting and fast-acting. The EnCaps process makes cannabinoids water-soluble and therefore more readily absorbed within the body. This dramatically improves both onset time and overall bioavailability, creating a more effective product.

Atlas Thrive – Powered by MÜV is expected to be rolled out in Shoppers Drug Mart and other cannabis stores across Canada starting in Q4, 2020.

About AltMed Enterprises – Alternative Medical Enterprises, LLC, headquartered in Sarasota, FL and doing business as AltMed Enterprises, is a fully integrated medical cannabis company that brings compassion, community engagement and pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.

About MÜV™ – The MÜV™ brand of medical cannabis infused products was launched in Arizona in 2016 and quickly gained international attention and recognition. MÜV Dispensary by AltMed Florida was formed a year later through the partnership of AltMed Enterprises and Plants of Ruskin, a multi-generational Florida agricultural leader. Through continual research and development, MÜV has received multiple patents for the award-winning MÜV Products line that provides quality, consistent and reliable medical cannabis products to patients at all 26 locations (one in Arizona muv-az.com, 25 in Florida muvfl.com, and more added each month). Patients are encouraged to place reservations online at muvfl.com for in-store pickup, order for delivery, or visit any one of the 26 MÜV Dispensaries for alternative medical cannabis medicine you can trust.

About Atlas Biotechnologies Inc. (“Atlas”) and Atlas Growers, LTD. – Atlas is based in Edmonton, Alberta, Canada and its wholly owned subsidiaries, Atlas Growers Ltd. & Atlas Thrive, is federally licensed for cultivation and production of cannabis products, with a focus on medical use markets. Atlas currently operates a purpose-built 38,000 square foot laboratory where it expects to produce 5,500 kg of dried cannabis annually and also has in-house capacity to refine cannabis into pure, isolated cannabinoid concentrates as well as specialized medical formulations in large volumes. Short-term plans include expanding extraction operations to 200,000 kg annual capacity.

Forward-Looking Statements – To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking in nature and merely express our beliefs, expectations or opinions. For example, words such as “may,” “should,” “estimates,” “predicts,” “continues,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “potential,” “strategy” and similar expressions are intended to identify forward-looking statements. Such statements are based on current expectations or estimates and involve a number of known and unknown risks and uncertainties that could cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, the following: (i) our ability to implement our business strategy of distributing high quality cannabis products where permissible under applicable law; (ii) availability and cost of additional capital; (iii) our ability to attract, retain and motivate qualified employees and management; (iv) the impact of federal, state or local government regulations; (v) competition in the cannabis industry; (vi) our ability to generate revenues; and (vii) litigation in connection with our business. All forward-looking statements included in this press release and attributable to us or any person acting on our behalf are qualified by this cautionary statement. Forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.

Share article on social media or email:

Phlexglobal Partners with PRA Health Sciences to create the Global TMF Center of Excellence


TMF Center of Excellence

PhlexTMF technology supports PRA’s TMF Center of Excellence

PhlexGlobal’s TMF system is a market-leading technology that sets the standard for inspection readiness. Barb Hoff Vice President PRA Health Sciences

Phlexglobal announced today the successful creation and implementation of the Global TMF Center of Excellence with partner PRA Health Sciences (NASDAQ: PRAH), one of the world’s leading global contract research organizations. By leveraging Phlexglobal’s industry leadership in eTMF technology innovation and authoritative expertise in Trial Master File best practices, PRA continues to ensure that its customers achieve and maintain lasting TMF compliance – in accordance with rapidly evolving regulatory mandates.

Given the increasingly critical role played by the Trial Master File for supporting Good Clinical Practice (GCP), audit and inspection preparedness, and streamlined submissions, PRA conducted a comprehensive, multi-round review of leading TMF providers and chose Phlexglobal after a competitive bidding process. Building and implementation of PRA’s fit-for-purpose TMF Center of Excellence solution commenced shortly after the project award was given in early 2019.

“Setting the standard for industry best practices, PhlexGlobal’s eTMF solution is designed for CRO and sponsor collaboration, which provides our customers with TMF visibility throughout the life of a project,” said Barb Hoff, Vice President at PRA Health Sciences. “PhlexGlobal’s TMF system is a market-leading technology that sets the standard for inspection readiness. The partnership with PhlexGlobal has provided PRA with valuable counsel and insights so that we are able to achieve the right alignment of people, process and technology to efficiently manage TMF health and enhance our business offerings.”

With insights from the Global TMF Center of Excellence, PRA assists top pharmaceutical and biotech sponsors in compliance and reducing risk by ensuring ongoing inspection-readiness with expert management of the quality, completeness, and timeliness of the Trial Master File. PhlexTMF technology supports this by providing effective sponsor oversight, streamlining collaboration and communication, and easily managing millions of documents across hundreds of studies.

“We are honored to work with PRA to provide high-quality TMF compliance to their customers,” said John McNeill, CEO of Phlexglobal. “As an industry leader consistently ranked among the top CROs and best employers worldwide, PRA recognized the critical importance of a high-quality Trial Master File for effective clinical development following GCP as well as successful submissions.”

PhlexTMF is the industry’s only eTMF solution that seamlessly incorporates both sponsor TMF requirements and the business practices of Contract Research Organizations (CROs) and Academic Research Organizations (AROs) to support their customers. With capabilities including the industry’s first AI-assisted indexing, embedded TMF Quality review, mobile scanning and classification, and the ability to easily manage multiple TMF structures, PhlexTMF helps organizations maximize their Trial Master File compliance and inspection-readiness.

About Phlexglobal

Phlexglobal is the leading technology and services organization for clinical and regulatory matters with a focus on helping clients to master their digital agenda via proven AI solutions. Phlexglobal combines software and leading expert services to offer a unique solutions portfolio with easy to achieve automation via data generation that lifts organizations to a new level of effectiveness.

PhlexTMF is the company’s Trial Master File software. Regulatory solutions including PhlexSubmission for eCTD and CTD, PhlexIDMP, PhlexEVMPD, and PhlexRIM are considered highly innovative in the industry for out-of-the-box best practices capabilities, automation technology, and user-focused design. PhlexDistiller, a machine learning platform that reads documents and converts unstructured content into structured data, achieves automation of regulatory and clinical processes and completes the end-to-end solutions offering from Phlexglobal. To learn more about Phlexglobal, please visit http://www.phlexglobal.com.

Media Inquiries: Chris Englerth, Head of Global Marketing

cenglerth@phlexglobal.com | +1 215-622-8798

About PRA Health Sciences

PRA Health Sciences is a full-service global contract research organization, providing a broad range of product development and data solution services to pharmaceutical and biotechnology companies around the world. PRA’s integrated services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. PRA’s global operations span more than 90 countries across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East, and more than 17,500 employees. Since 2000, PRA has participated in more than 4,000 clinical trials. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 95 products. To learn more about PRA, please visit http://www.prahs.com.

MEDIA INQUIRIES: Laurie Hurst, Sr. Director, Communications and Public Relations

hurstlaurie@prahs.com | +1-919-786-8435

Share article on social media or email:

Dr. David J. Weber Joins UV Innovators™ Scientific Advisory Board


UV Innovators (http://www.uvinnovators.com), an ultraviolet technology company, announced today that David J. Weber, M.D., M.P.H., has joined its scientific advisory board. Dr. Weber, a preeminent global expert in infection prevention, serves as Professor of Medicine and Pediatrics at the University of North Carolina (UNC) School of Medicine, Professor of Epidemiology at the UNC Gillings School of Global Public Health, Associate Chief Medical Officer for UNC Health Care, and Medical Director of the Department of Infection Prevention for the UNC Medical Center. Since the first days of the outbreak, he has been working with the CDC, FDA, and other local health departments to understand the coronavirus (COVID-19) and its mechanism for community spreading.

“The global public health and financial impact of COVID-19 have put a strain on resources and created a substantial need to find therapeutic and preventative solutions quickly,” stated Dr. Weber. “People are coming to understand the necessity of social distancing, wearing a face mask, having good hand hygiene and effective surface disinfection solutions,” Weber added.

“Dr. Weber is on the frontlines of infection prevention, especially concerning antibiotic-resistant pathogens, disinfection methodology, and outbreak investigations. He has a personal goal to eliminate healthcare-associated infections which is aligned with our company’s mission,” stated Dr. Nicholas Medendorp, Jr., CEO of UV Innovators. “A study in the New England Journal of Medicine has identified that SARS-CoV-2, the virus that causes COVID-19, can survive and remain contagious on surfaces for many hours. There must be further expansion into UVC disinfection as an effective means of combating this deadly virus,” states Dr. Medendorp.

The UV Innovators team designs and develops ultraviolet technology, conducts pathogen inactivation testing, and produces industrial-grade UVC disinfection solutions to all industries in need of infection control and prevention. To learn more about how SARS-CoV-2 can live on surfaces for up to 8 hours, review this article in the New England Journal of Medicine (382; 2020, 16, 1564-1567).

About UV Innovators

UV Innovators, LLC uses its extensive illumination and medical device knowledge to create intellectual property that delivers disinfection solutions across a vast set of markets — from private aviation and clinical care facilities, to healthy office buildings and schools. The commercialization of a UVC product that delivers the germ deactivating power of a disinfection tower, with the speed and mobility of a handheld device, UV Innovators has redefined the standard of surface disinfection. For more information, visit http://www.uvinnovators.com or contact info@uvinnovators.com.

About Dr. Weber

Dr. Weber is a world-renowned leader in the treatment of infectious diseases. He is the Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine and Pediatrics at the University of North Carolina (UNC) School of Medicine and Professor of Epidemiology in the UNC Gillings School of Global Public Health, Associate Chief Medical Officer for UNC Medical Center and serves as Medical Director, Department of Infection Prevention, UNC Medical Center. Additionally, Dr. Weber is the Associate Director of the North Carolina Statewide Infection Control Program (SPICE). Dr. Weber holds his M.D. from the University of California, and his M.P.H., School of Public Health, Harvard University. Dr. Weber has been Board certified in Internal Medicine, Infectious Diseases, Critical Care Medicine and Preventive Medicine. Dr. Weber is cited as an author in >440 scientific publications by PubMed.

Forward-looking Statements

Except for historical information, all the statements, expectations, and assumptions contained in this press release are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially to include risks associated with technology development process; reliance on key personnel; the early stage of our business; competition; and other risks described in other Company press releases and presentations. UV Innovators assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Media Contact

Sparkpr for UV Innovators

uvinnovators@sparkpr.com

503-507-4758

Share article on social media or email: